Managers

Digital health company LindaCare grabs Series B funding

Belgium and Connecticut-based LindaCare, a digital health company specializing in remote patient monitoring solutions for chronic disease management, has raised 7 million euros in Series B funding. The investors included Philips, PMV, Capricorn ICT Arkiv and Connecticut Innovations.

Skyhawk Therapeutics pulls in $8 mln seed

Waltham, Massachusetts-based Skyhawk Therapeutics Inc, a developer of small molecule therapeutics that correct RNA expression, has secured $8 million in seed funding. The investors included Alexandria Venture Investments.

Ultivue nets $20 mln Series B

Cambridge, Massachusetts-based Ultivue, a developer of reagent-driven solutions for high-performance biological imaging in situ, has raised $20 million in Series B funding round. ARCH Venture Partners led the round.

IA Capital Group raises $15.3 mln toward $100 mln venture fund

IA Capital Group has raised $15.3 million toward a $100 million venture fund, according to a filing with the SEC.

Capital A Partners seeks $60 mln fund

Capital A Partners is seeking $60 million for its latest fund. The pool will focus on Nordic B2B tech startups.

Almanac rakes in $30 mln for venture fund

Almanac has raised $30 million for its venture fund. Almanac is focused on investing in the food and hospitality sector. So far, Almanac has invested in Nona Lim, a line of Asian-inspired heat-and-sip soup cups, bone broths and noodles; Pilotworks, an operator of culinary incubators in the U.S.; and BlueCart, a wholesale order management platform for buyers and sellers in the hospitality industry.

Bios Partners targets $50 mln second fund

Bios Partners in Fort Worth, Texas, has filed to raise a $50 million second fund, according to a regulatory filing. The filing for Bios Fund II NT lists Leslie Kries, Jr. and Aaron Fletcher as managing partners.

New York Life Ventures announces more than $200 mln of committed capital

New York Life Ventures said it has more than $200 million of committed capital to invest.

Eureka Therapeutics hauls in $60 mln Series D

Emeryville, California-based Eureka Therapeutics Inc, a clinical stage biotechnology focused on treating solid tumors, has closed $60 million in Series D financing. Acorn Pacific Ventures led the round with participation from other investors that included GP Capital.

Energy Innovation Capital collects over $130 mln for maiden fund

Energy Innovation Capital has raised over $130 million for its debut fund, according to an SEC listing. No target was listed on the document. The venture firm targets large oil, gas or energy markets.